Roche will present new long-term data on trontinemab and the Elecsys pTau217 blood test at AAIC 2026, highlighting advancements in Alzheimer's diagnostics and treatment.

ClinicalJuly 7, 2026

Roche presents new Alzheimer’s data at AAIC 2026, highlighting trontinemab and blood tests

Roche will present new long-term data on trontinemab and the Elecsys pTau217 blood test at AAIC 2026.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts(2)

Topline Data

Roche — Trontinemab

July 7, 2026 · N/A

Topline Data

Roche — Trontinemab

July 7, 2026 · N/A

Indications

Alzheimer's Disease →

Therapeutic areas

Alzheimer's Disease →

Neurology →

Neurology · Alzheimer's Disease →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.